FH and leiomyosarcoma: In summary, addressing the challenges posed by FH deficiency in gynecologic oncology requires a multifaceted approach encompassing early detection, targeted therapies, clinical trials, and ongoing research aimed at also identifying the potential role of FH deficiency in leiomyoma transformation in leiomyosarcoma.